Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer

xlomafota13 shared this article with you from Inoreader Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer Via radioactive iodine Biomark Med. 2021 Jul 9. doi: 10.2217/bmm-2020-0745. Online ahead of print. ABSTRACT Aim: Urinary iodine concentration (UIC) may assess radioactive iodine ablation. Materials & methods: According the 2015 American Thyroid Association guidelines, patients were categorized into low- to intermediate-risk or high-risk groups. The iodine concentration in the morning urine specimens was measured by the ceric ion-arsenious acid method. Results: In the low- to inte rmediate-risk group (113 cases), nonexcellent response (non-ER) was associated with higher UIC, higher UIC subgroups (p < 0.05), higher pre-ablative stimulated thyroglobulin levels (p < 0.01). In the high-risk group (68 cases), the non-ER rate was higher in the higher pre-ablative stimulated thyroglobulin group (p < 0.01), but not significantly different between the UIC and UIC subgroups (p > 0.05). Conclusion: The non-ER rate was related to UIC in the low- to intermediate-risk group; however, UIC did not affect the non-ER rate in the high-risk group. PMID:34241549 | DOI:10.2217/bmm-2020-0745 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.